AT309696B - Process for the preparation of new D-arabinofuranosylpurine derivatives - Google Patents

Process for the preparation of new D-arabinofuranosylpurine derivatives

Info

Publication number
AT309696B
AT309696B AT1028370A AT1028370A AT309696B AT 309696 B AT309696 B AT 309696B AT 1028370 A AT1028370 A AT 1028370A AT 1028370 A AT1028370 A AT 1028370A AT 309696 B AT309696 B AT 309696B
Authority
AT
Austria
Prior art keywords
arabinofuranosylpurine
derivatives
preparation
new
arabinofuranosylpurine derivatives
Prior art date
Application number
AT1028370A
Other languages
German (de)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of AT309696B publication Critical patent/AT309696B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT1028370A 1969-11-17 1970-11-16 Process for the preparation of new D-arabinofuranosylpurine derivatives AT309696B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (1)

Publication Number Publication Date
AT309696B true AT309696B (en) 1973-08-27

Family

ID=25369972

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1028370A AT309696B (en) 1969-11-17 1970-11-16 Process for the preparation of new D-arabinofuranosylpurine derivatives

Country Status (26)

Country Link
US (1) US3666856A (en)
JP (1) JPS5429520B1 (en)
AT (1) AT309696B (en)
BE (1) BE759011A (en)
BR (1) BR6915136D0 (en)
CA (1) CA967564A (en)
CH (2) CH555833A (en)
CS (1) CS181701B2 (en)
DE (1) DE2056327C2 (en)
DK (1) DK128117B (en)
ES (2) ES385590A1 (en)
FI (1) FI54315C (en)
FR (1) FR2073364B1 (en)
GB (2) GB1338905A (en)
HU (1) HU163812B (en)
IE (1) IE34737B1 (en)
IL (1) IL35658A (en)
LU (1) LU62071A1 (en)
MC (1) MC869A1 (en)
NL (1) NL171589C (en)
NO (1) NO128156B (en)
PL (1) PL81167B1 (en)
SE (1) SE385374B (en)
YU (2) YU35033B (en)
ZA (1) ZA707722B (en)
ZM (1) ZM12970A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (en) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin USE OF ADENOSINE IN THE TREATMENT OF HERPES
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
FI895447A0 (en) * 1988-03-16 1989-11-15 Scripps Clinic Res SUBSTITUTE ADENINDERIVAT ANVAENDBARA SOM TERAPEUTISKA SUBSTANSER.
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
EP1334104A2 (en) 2000-07-07 2003-08-13 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (en) * 2015-06-25 2018-05-18 新乡学院 A kind of preparation method of 2- amino arabinosy ladenosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070413A (en) * 1962-11-15 1967-06-01 Sankyo Co A process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (en) * 1996-09-20 1998-04-14 Sony Corp Production control method

Also Published As

Publication number Publication date
YU35034B (en) 1980-06-30
YU35033B (en) 1980-06-30
IE34737B1 (en) 1975-08-06
BR6915136D0 (en) 1973-04-19
DE2056327A1 (en) 1971-06-03
MC869A1 (en) 1971-09-28
NO128156B (en) 1973-10-08
FR2073364A1 (en) 1971-10-01
FR2073364B1 (en) 1974-03-22
HU163812B (en) 1973-10-27
FI54315C (en) 1978-11-10
JPS5429520B1 (en) 1979-09-25
NL171589C (en) 1983-04-18
PL81167B1 (en) 1975-08-30
ZM12970A1 (en) 1972-07-21
IE34737L (en) 1971-05-17
IL35658A (en) 1974-10-22
BE759011A (en) 1971-05-17
FI54315B (en) 1978-07-31
DK128117B (en) 1974-03-04
CA967564A (en) 1975-05-13
LU62071A1 (en) 1971-08-12
US3666856A (en) 1972-05-30
ES413787A1 (en) 1976-01-16
GB1338905A (en) 1973-11-28
YU201978A (en) 1979-12-31
CS181701B2 (en) 1978-03-31
YU280670A (en) 1979-12-31
GB1338906A (en) 1973-11-28
CH555833A (en) 1974-11-15
CH555344A (en) 1974-10-31
ZA707722B (en) 1972-06-28
SE385374B (en) 1976-06-28
NL171589B (en) 1982-11-16
IL35658A0 (en) 1971-01-28
NL7016766A (en) 1971-05-19
ES385590A1 (en) 1973-10-01
DE2056327C2 (en) 1984-10-11

Similar Documents

Publication Publication Date Title
CH535788A (en) Process for the preparation of new benzodiazepine derivatives
AT309696B (en) Process for the preparation of new D-arabinofuranosylpurine derivatives
CH537930A (en) Process for the preparation of new substituted N-allyl-2-arylamino-imidazoline- (2)
AT301752B (en) Process for the preparation of new pleuromutilin derivatives
CH529764A (en) Process for the preparation of new pyrazoline derivatives
AT306256B (en) Process for the production of new benzomorphane derivatives
AT298478B (en) Process for the preparation of new 2-aminoindane derivatives
AT301753B (en) Process for the preparation of new pleuromutilin derivatives
AT310361B (en) Process for the production of new evomonoside derivatives
AT299916B (en) Process for the preparation of new bis-aminobenzoates
AT301522B (en) Process for the preparation of new substituted 2-phenyl-2-hydroxy- or acyloxy-1,1-dihaloethanes
AT289776B (en) Process for the preparation of new 1-carbamoyl-3-aroylpyrrolidines
CH542210A (en) Process for the preparation of new dibenzazepine derivatives
CH516591A (en) Process for the preparation of new thiazolopyrrolopyrimidines
CH530988A (en) Process for the preparation of new diallylaminoalkanoylamides
AT297234B (en) Process for the preparation of new N (6) -alkyl-adenosine derivatives
CH498120A (en) Process for the preparation of new indenopyridine derivatives
CH513119A (en) Process for the preparation of new halocolchicine derivatives
AT301036B (en) Process for the preparation of new neriifolin derivatives
AT296296B (en) Process for the preparation of new triazole derivatives
AT305253B (en) Process for the preparation of new diphenoxyacetamides
AT319914B (en) Process for the preparation of new triazapentadienes
CH539065A (en) Process for the preparation of new triazolopyrimidine derivatives
CH533633A (en) Process for the preparation of new phenanthrotriazolyl derivatives
AT299176B (en) Process for the preparation of new hexahydrophenanthrene derivatives

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee